Selected News from Today's FirstWord
US Supreme Court rules drugmakers can be challenged on "pay-for-delay" deals
The US Supreme Court ruled 5-3 on Monday that drugmakers entering pay-for-delay deals surrounding generic medicines can be sued, reversing a lower court decision that had effectively insulated Full story
- Royalty Pharma bid set to lapse as Elan shareholders back share repurchase - (Ref. PR Newswire; Marketwire; The Irish Times; The Miami Herald; Elan; Fidelity; Bloomberg; Financial Times; London South East; NASDAQ; TheStreet; The Wall Street Journal)
- Sources say orphan drug developer ViroPharma may be takeover target - (Ref. CNBC; Bloomberg; Investors.com)
- Teva to buy respiratory drug developer MicroDose for $165 million - (Ref. FinanzNachrichten; Bloomberg; SmartMoney; Globes; iStockAnalyst)
- Amicus' shares fall on decision to delay FDA filing for Fabry disease drug - (Ref. TheStreet; Xconomy; The Wall Street Journal)
- Johnson & Johnson boosts cancer drug pipeline with $1-billion deal to buy Aragon Pharmaceuticals - (Ref. Fidelity; livemint.com; Morningstar; Bloomberg; PR Newswire; Chicago Tribune; MarketWatch; NASDAQ; Marketwire)
Also in the News
- Products:
- Avastin,
- buprenorphine,
- fludarabine,
- fluticasone,
- naloxone,
- Pradaxa,
- TGR-1202
- Companies:
- Acetylon,
- Clovis Oncology,
- DNAtrix,
- GSK,
- Roche,
- Siemens Healthcare,
- Zealand Pharma
- Markets:
- EU,
- India,
- United States
FirstWord Dossier Reports
www.fwreports.com
**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.Click here to see our recent reports.
Most Read Stories in the Past Week
Recent Reports
- Building Strong Market Access Teams
- Biosimilars Regulatory Update: an evolving landscape
- Pharma Social Media Campaigns: current thinking and future outlook
- Pharma Market Insights: Closed Loop Marketing
- Pharma Sales Force Innovations: technology, training and rewards
- Pharma YouTube Channels: Content and Comment (Nexus Report)
- The Medical Device Outlook in Emerging Markets - (FirstShelf)
- The Hepatitis Market Outlook to 2015 - (FirstShelf)
- Digital Doctors: Marketing to Online Networks
- Generic Substitution: Taking a Narrow View?
- Closing the Loop: Beyond Digital Detailing
- Pharma Marketing in Latin America
- Biosimilars: Surveying the Market Landscape